{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:17:29Z","timestamp":1794334649324,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la recherche M\u00e9dicale","doi-asserted-by":"crossref","award":["DCM20121225761"],"award-info":[{"award-number":["DCM20121225761"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00018-017-2583-0","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T03:18:20Z","timestamp":1498879100000},"page":"4353-4367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["V\u03b39V\u03b42 T cell activation by strongly agonistic nucleotidic phosphoantigens"],"prefix":"10.1007","volume":"74","author":[{"given":"Morgane","family":"Moulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Alguacil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Mehtougui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Peyrottes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"2583_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cellimm.2015.04.008","volume":"296","author":"EJ Adams","year":"2015","unstructured":"Adams EJ, Gu S, Luoma AM (2015) Human gamma delta T cells: evolution and ligand recognition. Cell Immunol 296:31\u201340","journal-title":"Cell Immunol"},{"key":"2583_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","volume":"32","author":"YH Chien","year":"2014","unstructured":"Chien YH, Meyer C, Bonneville M (2014) \u03b3\u03b4 T cells: first line of defense and beyond. Annu Rev Immunol 32:121\u2013155","journal-title":"Annu Rev Immunol"},{"key":"2583_CR3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clim.2016.07.012","volume":"172","author":"D Kabelitz","year":"2016","unstructured":"Kabelitz D (2016) Human \u03b3\u03b4 T cells: from a neglected lymphocyte population to cellular immunotherapy: a personal reflection of 30\u00a0years of \u03b3\u03b4 T cell research. Clin Immunol 172:90\u201397","journal-title":"Clin Immunol"},{"key":"2583_CR4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/ph8010040","volume":"8","author":"H Kobayashi","year":"2015","unstructured":"Kobayashi H, Tanaka Y (2015) \u03b3\u03b4 T cell immunotherapy\u2014a review. Pharmaceuticals 8:40\u201361","journal-title":"Pharmaceuticals"},{"key":"2583_CR5","first-page":"688","volume":"5","author":"S Gu","year":"2014","unstructured":"Gu S, Nawrocka W, Adams EJ (2014) Sensing of pyrophosphate metabolites by V\u03b39V\u03b42 T cells. Front Immunol 5:688","journal-title":"Front Immunol"},{"key":"2583_CR6","first-page":"657","volume":"5","author":"C Harly","year":"2014","unstructured":"Harly C, Peigne CM, Scotet E (2014) Molecules and mechanisms implicated in the peculiar antigenic activation process of human V\u03b39V\u03b42 T cells. Front Immunol 5:657","journal-title":"Front Immunol"},{"key":"2583_CR7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0014-5793(03)00483-6","volume":"544","author":"M Eberl","year":"2003","unstructured":"Eberl M, Hintz M, Reichenberg A et al (2003) Microbial isoprenoid biosynthesis and human \u03b3\u03b4 T cell activation. FEBS Lett 544:4\u201310","journal-title":"FEBS Lett"},{"key":"2583_CR8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4049\/jimmunol.1501833","volume":"197","author":"AM Kilcollins","year":"2016","unstructured":"Kilcollins AM, Li J, Hsiao CH et al (2016) HMBPP analog prodrugs bypass energy-dependent uptake to promote efficient BTN3A1-mediated malignant cell lysis by V\u03b39V\u03b42 T lymphocyte effectors. J Immunol 197:419\u2013428","journal-title":"J Immunol"},{"key":"2583_CR9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1084\/jem.20021500","volume":"197","author":"HJ Gober","year":"2003","unstructured":"Gober HJ, Kistowska M, Angman L et al (2003) Human T cell receptor \u03b3\u03b4 cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 197:163\u2013168","journal-title":"J Exp Med"},{"key":"2583_CR10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fimmu.2014.00219","volume":"5","author":"G Libero De","year":"2014","unstructured":"De Libero G, Lau SY, Mori L (2014) Phosphoantigen presentation to TCR \u03b3\u03b4 cells, a conundrum getting less gray zones. Front Immunol 5:679","journal-title":"Front Immunol"},{"key":"2583_CR11","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2012-05-430470","volume":"120","author":"C Harly","year":"2012","unstructured":"Harly C, Guillaume Y, Nedellec S et al (2012) Key implication of CD277\/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human \u03b3\u03b4 T-cell subset. Blood 120:2269\u20132279","journal-title":"Blood"},{"key":"2583_CR12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.immuni.2014.03.003","volume":"40","author":"A Sandstrom","year":"2014","unstructured":"Sandstrom A, Peigne CM, Leger A et al (2014) The intracellular B30.2 domain of butyrophilin 3A1 Binds phosphoantigens to mediate activation of human V\u03b39V\u03b42 T cells. Immunity 40:490\u2013500","journal-title":"Immunity"},{"key":"2583_CR13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fimmu.2014.00648","volume":"5","author":"MM Karunakaran","year":"2014","unstructured":"Karunakaran MM, Herrmann T (2014) The V\u03b39V\u03b42 T cell antigen receptor and butyrophilin-3 A1: models of interaction, the possibility of co-evolution, and the case of dendritic epidermal T cells. Front Immunol 5:648","journal-title":"Front Immunol"},{"key":"2583_CR14","doi-asserted-by":"crossref","first-page":"32780","DOI":"10.1074\/jbc.M112.384354","volume":"287","author":"A Palakodeti","year":"2012","unstructured":"Palakodeti A, Sandstrom A, Sundaresan L et al (2012) The molecular basis for modulation of human V\u03b39V\u03b42 T cell responses by CD277\/butyrophilin-3 (BTN3A)-specific antibodies. J Biol Chem 287:32780\u201332790","journal-title":"J Biol Chem"},{"key":"2583_CR15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4049\/jimmunol.1300658","volume":"191","author":"H Wang","year":"2013","unstructured":"Wang H, Henry O, Distefano MD et al (2013) Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human V\u03b32V\u03b42 T cells. J Immunol 191:1029\u20131042","journal-title":"J Immunol"},{"key":"2583_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646818","author":"L Starick","year":"2017","unstructured":"Starick L, Riano F, Karunakaran MM et al (2017) Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates V\u03b39V\u03b42 TCR clonotypes and interferes with phosphoantigen activation. Eur J Immunol. doi:\n                        10.1002\/eji.201646818\n                        \n                     (Epub ahead of print)","journal-title":"Eur J Immunol"},{"key":"2583_CR17","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ni.2665","volume":"14","author":"S Vavassori","year":"2013","unstructured":"Vavassori S, Kumar A, Wan GS et al (2013) Butyrophilin 3A1 binds phosphorylated antigens and stimulates human \u03b3\u03b4 T cells. Nat Immunol 14:908\u2013916","journal-title":"Nat Immunol"},{"key":"2583_CR18","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.4049\/jimmunol.1601910","volume":"198","author":"CM Peigne","year":"2017","unstructured":"Peigne CM, Leger A, Gesnel MC et al (2017) The juxtamembrane domain of butyrophilin BTN3A1 controls phosphoantigen-mediated activation of human V\u03b39V\u03b42 T cells. J Immunol 198:4228\u20134234","journal-title":"J Immunol"},{"key":"2583_CR19","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.1401064","volume":"194","author":"DA Rhodes","year":"2015","unstructured":"Rhodes DA, Chen HC, Price AJ et al (2015) Activation of human \u03b3\u03b4 T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin. J Immunol 194:2390\u20132398","journal-title":"J Immunol"},{"key":"2583_CR20","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.celrep.2016.04.081","volume":"15","author":"Z Sebestyen","year":"2016","unstructured":"Sebestyen Z, Scheper W, Vyborova A et al (2016) RhoB mediates phosphoantigen recognition by V\u03b39V\u03b42 T cell receptor. Cell Rep 15:1973\u20131985","journal-title":"Cell Rep"},{"key":"2583_CR21","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/eji.201444712","volume":"44","author":"F Riano","year":"2014","unstructured":"Riano F, Karunakaran MM, Starick L et al (2014) V\u03b39V\u03b42 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6. Eur J Immunol 44:2571\u20132576","journal-title":"Eur J Immunol"},{"key":"2583_CR22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.8146660","volume":"264","author":"P Constant","year":"1994","unstructured":"Constant P, Davodeau F, Peyrat MA et al (1994) Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 264:267\u2013270","journal-title":"Science"},{"key":"2583_CR23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0014-5793(01)03191-X","volume":"509","author":"M Hintz","year":"2001","unstructured":"Hintz M, Reichenberg A, Altincicek B et al (2001) Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human \u03b3\u03b4 T cells in Escherichia coli. FEBS Lett 509:317\u2013322","journal-title":"FEBS Lett"},{"key":"2583_CR24","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/eji.1830261011","volume":"26","author":"Y Poquet","year":"1996","unstructured":"Poquet Y, Constant P, Halary F et al (1996) A novel nucleotide-containing antigen for human blood gamma delta T lymphocytes. Eur J Immunol 26:2344\u20132349","journal-title":"Eur J Immunol"},{"key":"2583_CR25","doi-asserted-by":"crossref","first-page":"e953410","DOI":"10.4161\/21624011.2014.953410","volume":"3","author":"G Gruenbacher","year":"2014","unstructured":"Gruenbacher G, Nussbaumer O, Gander H et al (2014) Stress-related and homeostatic cytokines regulate V\u03b39V\u03b42 T-cell surveillance of mevalonate metabolism. Oncoimmunology 3:e953410","journal-title":"Oncoimmunology"},{"key":"2583_CR26","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.4049\/jimmunol.0901085","volume":"183","author":"P Vantourout","year":"2009","unstructured":"Vantourout P, Mookerjee-Basu J, Rolland C et al (2009) Specific requirements for V\u03b39V\u03b42 T cell stimulation by a natural adenylated phosphoantigen. J Immunol 183:3848\u20133857","journal-title":"J Immunol"},{"key":"2583_CR27","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.lfs.2007.08.007","volume":"81","author":"H Monkkonen","year":"2007","unstructured":"Monkkonen H, Ottewell PD, Kuokkanen J et al (2007) Zoledronic acid-induced IPP\/ApppI production in vivo. Life Sci 81:1066\u20131070","journal-title":"Life Sci"},{"key":"2583_CR28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bjp.0706628","volume":"147","author":"H Monkkonen","year":"2006","unstructured":"Monkkonen H, Auriola S, Lehenkari P et al (2006) A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. Br J Pharmacol 147:437\u2013445","journal-title":"Br J Pharmacol"},{"key":"2583_CR29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4049\/jimmunol.167.1.36","volume":"167","author":"CT Morita","year":"2001","unstructured":"Morita CT, Lee HK, Wang H et al (2001) Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells. J Immunol 167:36\u201341","journal-title":"J Immunol"},{"key":"2583_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/375155a0","volume":"375","author":"Y Tanaka","year":"1995","unstructured":"Tanaka Y, Morita CT, Tanaka Y et al (1995) Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375:155\u2013158","journal-title":"Nature"},{"key":"2583_CR31","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.4049\/jimmunol.0904024","volume":"184","author":"J Mookerjee-Basu","year":"2010","unstructured":"Mookerjee-Basu J, Vantourout P, Martinez LO et al (2010) F1-adenosine triphosphatase displays properties characteristic of an antigen presentation molecule for V\u03b39V\u03b42 T cells. J Immunol 184:6920\u20136928","journal-title":"J Immunol"},{"key":"2583_CR32","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1126\/science.1978758","volume":"250","author":"P Fisch","year":"1990","unstructured":"Fisch P, Malkovsky M, Kovats S et al (1990) Recognition by human V gamma 9\/V delta 2 T cells of a GroEL homolog on Daudi Burkitt\u2019s lymphoma cells. Science 250:1269\u20131273","journal-title":"Science"},{"key":"2583_CR33","doi-asserted-by":"crossref","first-page":"16812","DOI":"10.1074\/jbc.M111.327650","volume":"287","author":"Y Dai","year":"2012","unstructured":"Dai Y, Chen H, Mo C et al (2012) Ectopically expressed human tumor biomarker MutS homologue 2 is a novel endogenous ligand that is recognized by human \u03b3\u03b4 T cells to induce innate anti-tumor\/virus immunity. J Biol Chem 287:16812\u201316819","journal-title":"J Biol Chem"},{"key":"2583_CR34","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1039\/C5NJ03614C","volume":"40","author":"J Alguacil","year":"2016","unstructured":"Alguacil J, Reyes D, Aubin Y et al (2016) Exploring synthetic pathways for nucleosidic derivatives of potent phosphoantigens. New J Chem 40:6046\u20136052","journal-title":"New J Chem"},{"key":"2583_CR35","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/jm701101g","volume":"51","author":"A Boedec","year":"2008","unstructured":"Boedec A, Sicard H, Dessolin J et al (2008) Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate. J Med Chem 51:1747\u20131754","journal-title":"J Med Chem"},{"key":"2583_CR36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.chembiol.2014.06.006","volume":"21","author":"CH Hsiao","year":"2014","unstructured":"Hsiao CH, Lin X, Barney RJ et al (2014) Synthesis of a phosphoantigen prodrug that potently activates V\u03b39V\u03b42 T-lymphocytes. Chem Biol 21:945\u2013954","journal-title":"Chem Biol"},{"key":"2583_CR37","doi-asserted-by":"crossref","first-page":"e1002040","DOI":"10.1371\/journal.ppat.1002040","volume":"7","author":"MS Davey","year":"2011","unstructured":"Davey MS, Lin CY, Roberts GW et al (2011) Human neutrophil clearance of bacterial pathogens triggers anti-microbial \u03b3\u03b4 T cell responses in early infection. PLoS Pathog 7:e1002040","journal-title":"PLoS Pathog"},{"key":"2583_CR38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/1074-7613(95)90178-7","volume":"3","author":"CT Morita","year":"1995","unstructured":"Morita CT, Beckman EM, Bukowski JF et al (1995) Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity 3:495\u2013507","journal-title":"Immunity"},{"key":"2583_CR39","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.1600913","volume":"197","author":"PT Nerdal","year":"2016","unstructured":"Nerdal PT, Peters C, Oberg HH et al (2016) Butyrophilin 3A\/CD277-dependent activation of human \u03b3\u03b4 T cells: accessory cell capacity of distinct leukocyte populations. J Immunol 197:3059\u20133068","journal-title":"J Immunol"},{"key":"2583_CR40","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1084\/jem.183.4.1917","volume":"183","author":"S Valitutti","year":"1996","unstructured":"Valitutti S, Muller S, Dessing M et al (1996) Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med 183:1917\u20131921","journal-title":"J Exp Med"},{"key":"2583_CR41","first-page":"386545","volume":"2010","author":"Q Ma","year":"2010","unstructured":"Ma Q, Wang Y, Lo AS et al (2010) Cell density plays a critical role in ex vivo expansion of T cells for adoptive immunotherapy. J Biomed Biotechnol 2010:386545","journal-title":"J Biomed Biotechnol"},{"key":"2583_CR42","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.4049\/jimmunol.1300603","volume":"191","author":"O Nussbaumer","year":"2013","unstructured":"Nussbaumer O, Gruenbacher G, Gander H et al (2013) Essential requirements of zoledronate-induced cytokine and \u03b3\u03b4 T cell proliferative responses. J Immunol 191:1346\u20131355","journal-title":"J Immunol"},{"key":"2583_CR43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1126\/science.1110267","volume":"309","author":"M Brandes","year":"2005","unstructured":"Brandes M, Willimann K, Moser B (2005) Professional antigen-presentation function by human \u03b3\u03b4 T Cells. Science 309:264\u2013268","journal-title":"Science"},{"key":"2583_CR44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.celrep.2016.06.009","volume":"16","author":"G Gruenbacher","year":"2016","unstructured":"Gruenbacher G, Gander H, Rahm A et al (2016) Ecto-ATPase CD39 inactivates isoprenoid-derived V\u03b39V\u03b42 T cell phosphoantigens. Cell Rep 16:444\u2013456","journal-title":"Cell Rep"},{"key":"2583_CR45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0960-894X(03)00138-0","volume":"13","author":"A Reichenberg","year":"2003","unstructured":"Reichenberg A, Hintz M, Kletschek Y et al (2003) Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates Its potential to activate human \u03b3\u03b4 T cells but does not lead to competitive antagonism. Bioorg Med Chem Lett 13:1257\u20131260","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-017-2583-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2583-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2583-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T04:30:06Z","timestamp":1508992206000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-017-2583-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":45,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2583"],"URL":"https:\/\/doi.org\/10.1007\/s00018-017-2583-0","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,1]]}}}